Current progress in searching for clinically useful biomarkers of blood–brain barrier damage following cerebral ischemia

Ischemic stroke is a leading cause of death and disability. Fear of intracranial hemorrhage (ICH) has been the primary reason for withholding tissue plasminogen activator (tPA) and thrombectomy, the only two widely accepted treatments for ischemic stroke. Thrombolysis treatment is only allowed in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weili, Pan, Rong, Qi, Zhifeng, Liu, Ke Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329218/
https://www.ncbi.nlm.nih.gov/pubmed/30693340
http://dx.doi.org/10.4103/bc.bc_11_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329218/
https://www.ncbi.nlm.nih.gov/pubmed/30693340
http://dx.doi.org/10.4103/bc.bc_11_18

Ejemplares similares